← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
51	51 Candel Therapeutics CADL $682M	–	–	–	–
52	52 Celularity CELU $42.5M	–	–	–	–
53	53 Creative Medical Technology CELZ $6.07M	–	–	–	–
54	54 DELISTED CERo Therapeutics CERO	–	–	–	–
55	55 Calidi Biotherapeutics CLDI $2.3M	–	–	–	–
56	56 Coya Therapeutics COYA $103M	–	–	–	–
57	57 Caribou Biosciences CRBU $48.3M	–	–	–	–
58	58 DELISTED CARGO Therapeutics CRGX	–	–	–	–
59	59 CRISPR Therapeutics CRSP $4.95B	–	–	–	–
60	CYAD 60 DELISTED Celyad Oncology SA American Depositary Shares CYAD	–	–	–	–
61	DBTX 61 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	–	–	–	–
62	62 Precision BioSciences DTIL $168M	–	–	–	–
63	63 enGene Therapeutics ENGN $111M	–	–	–	–
64	64 Estrella Immunopharma ESLA $14.2M	–	–	–	–
65	65 FibroBiologics FBLG $7.08M	–	–	–	–
66	66 4D Molecular Therapeutics FDMT $699M	–	–	–	–
67	FRLN 67 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	–	–	–	–
68	68 DELISTED Generation Bio GBIO	–	–	–	–
69	69 CytoMed Therapeutics GDTC $10.1M	–	–	–	–
70	GMDA 70 DELISTED Gamida Cell Ltd. Ordinary Shares GMDA	–	–	–	–
71	71 Genprex GNPX $1.98M	–	–	–	–
72	72 Genenta Science GNTA $32.5M	–	–	–	–
73	GRCL 73 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	–	–	–	–
74	GRML 74 Greenland Mines Ltd GRML $81.3M	–	–	–	–
75	75 Fractyl Health GUTS $54.3M	–	–	–	–